Northwest Quadrant Wealth Management, LLC Amgen Inc Transaction History

Northwest Quadrant Wealth Management, LLC

$473 Million
Q3 2025

A detailed history of Northwest Quadrant Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Northwest Quadrant Wealth Management, LLC holds 886 shares of AMGN stock, worth $302,755. This represents 0.05% of its overall portfolio holdings.

Number of Shares

886

Previous 880 0.68%

Holding current value

$302,755

Previous $245,000 2.04%

% of portfolio

0.05%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$271.18 - $309.22 $1,627 - $1,855	6 Added 0.68%	886 $250,000
Q2 2025 Jul 29, 2025	BUY	$262.28 - $309.85 $1,311 - $1,549	5 Added 0.57%	880 $245,000
Q1 2025 May 09, 2025	BUY	$258.59 - $327.36 $1,034 - $1,309	4 Added 0.46%	875 $272,000
Q4 2024 Feb 13, 2025	BUY	$258.78 - $328.31 $1,293 - $1,641	5 Added 0.58%	871 $227,000
Q3 2024 Oct 04, 2024	BUY	$309.38 - $337.38 $1,237 - $1,349	4 Added 0.46%	866 $279,000

Q2 2024 Jul 12, 2024	BUY	$262.75 - $319.31 $1,313 - $1,596	5 Added 0.58%	862 $269,000
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $8,334 - $10,061	-31 Reduced 3.49%	857 $243,000
Q4 2023 Jan 09, 2024	BUY	$255.7 - $288.46 $1,278 - $1,442	5 Added 0.57%	888 $255,000
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $193,067 - $239,699	883 New	883 $237,000
Q1 2023 Apr 10, 2023	BUY	$225.79 - $275.2 $1,354 - $1,651	6 Added 0.69%	871 $210,000
Q4 2022 Jan 30, 2023	BUY	$229.03 - $291.01 $198,110 - $251,723	865 New	865 $227,000
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $1,153 - $1,283	5 Added 0.59%	855 $211,000
Q1 2022 Apr 08, 2022	SELL	$219.27 - $242.57 $8,990 - $9,945	-41 Reduced 4.6%	850 $208,000
Q4 2021 Jan 26, 2022	SELL	$198.88 - $227.6 $48,924 - $55,989	-246 Reduced 21.64%	891 $200,000
Q3 2021 Oct 13, 2021	SELL	$212.27 - $248.7 $9,339 - $10,942	-44 Reduced 3.73%	1,137 $244,000
Q2 2021 Jul 20, 2021	BUY	$233.58 - $259.14 $1,167 - $1,295	5 Added 0.43%	1,181 $286,000
Q1 2021 Apr 14, 2021	BUY	$221.91 - $258.6 $1,331 - $1,551	6 Added 0.51%	1,176 $293,000
Q4 2020 Jan 22, 2021	BUY	$216.38 - $257.67 $1,081 - $1,288	5 Added 0.43%	1,170 $266,000
Q3 2020 Oct 13, 2020	BUY	$234.65 - $260.95 $938 - $1,043	4 Added 0.34%	1,165 $289,000
Q2 2020 Jul 09, 2020	BUY	$197.81 - $242.74 $989 - $1,213	5 Added 0.43%	1,161 $269,000
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $3,827 - $5,075	-21 Reduced 1.78%	1,156 $270,000
Q4 2019 Jan 21, 2020	SELL	$189.21 - $243.2 $36,706 - $47,180	-194 Reduced 14.15%	1,177 $283,000
Q3 2019 Oct 24, 2019	BUY	$174.11 - $208.62 $238,704 - $286,018	1,371 New	1,371 $278,000

Others Institutions Holding AMGN

# of Institutions

3,273

Shares Held

428M

Call Options Held

6.11M

Put Options Held

5.85M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Quadrant Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Quadrant Wealth Management, LLC with notifications on news.

Account

Northwest Quadrant Wealth Management, LLC Amgen Inc Transaction History